No consumer-focused AI Series B rounds detected
Key Questions
Has there been any consumer-focused AI Series B funding recently?
As of the 2026-04-02 check, no consumer-focused AI Series B rounds have been detected that meet mandatory filters including round size, named lead(s), traction/valuation, and cap-table details. Surveillance covered companies like Mirage/Captions ($75M growth financing), Doctronic ($40M Series B medical AI), and others, but none qualified. Monitoring remains active.
Why doesn't Mirage's funding for Captions count as a consumer AI Series B?
Mirage raised $75M in growth financing, not a Series B round, for its consumer video-editing AI app Captions. It fails to meet specific filters such as round type, named leads, and cap-table requirements. The funding was led by General Catalyst, but it does not qualify under the criteria.
What companies were checked in this surveillance?
The check included Mirage/Captions ($75M growth consumer video AI), Doctronic ($40M Series B medical AI), Highlight AI ($40M productivity), Sarvam (rumored $250M in India), and prior shorts like Littlebird, ElevenLabs, Allure, Evervault, Halter, OpusClip, Cloaked, Oasis, and Posh. None met the consumer-focused Series B filters. Ongoing surveillance continues.
As of 2026-04-04 check, surveillance including Conntour ($7M seed B2B security AI), 2025 funding roundup (no hits), Harvey ($200M $11B legal AI enterprise), CNBC India roundup (no hits), Mirage/Captions ($75M growth consumer video AI), Doctronic ($40M Series B med AI), Highlight AI ($40M productivity), Sarvam rumor ($250M India), funding shorts, prior Littlebird/ElevenLabs/Allure/Evervault/Halter/OpusClip/Cloaked/Oasis/Posh etc. produced no consumer Series B meeting mandatory filters (round size + named lead(s) + traction/valuation/cap-table). Monitoring active.